ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1207 • 2014 ACR/ARHP Annual Meeting

    Novel Role of Liver X Receptor Alpha (LXRα) in the Attenuation of TLR Signalling: Implications in Congenital Heart Block

    Susmita Bagchi1, Mark Halushka2, Robert M. Clancy1 and Jill P. Buyon1, 1Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Division of Cardiovascular Pathology, John Hopkins Pathology, Baltimore, MD

    Background/Purpose:  Anti-SSA/Ro associated congenital heart block provides a unique opportunity to examine the effector arm of immunity and define the molecular mechanisms that link maternal…
  • Abstract Number: 1206 • 2014 ACR/ARHP Annual Meeting

    Low Dose Colchicine Anti-Inflammatory Effects Are Transduced By AMP-Activated Protein Kinase (AMPK)

    Ru Bryan1, Robert Terkeltaub2 and Yun Wang3, 1Medicine-Rheumatology, VA Medical Center/University of California San Diego, San Diego, CA, 2Medicine-Rheumatology, VA Medical Ctr/University of California San Diego, San Diego, CA, 3Medicine-Rheumatology, VA Medical Ctr/UCSD, San Diego, CA

    Background/Purpose AMPK is a master metabolic energy regulator, whose tissue activity drops in response to nutritional excesses, alcohol consumption, and in obesity, metabolic syndrome and…
  • Abstract Number: 1205 • 2014 ACR/ARHP Annual Meeting

    Expression of Lectin-like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis

    Paulina Chalan1, Johan Bijzet2, Minke G. Huitema3, Bart-Jan Kroesen4, Elisabeth Brouwer1 and Annemieke M.H. Boots1, 1Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Dept. of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose Precursor Th17 lineage cells expressing CD161 are implicated in rheumatoid arthritis (RA) pathogenesis. CD4+CD161+ T cells were found to accumulate in RA synovial fluid…
  • Abstract Number: 1204 • 2014 ACR/ARHP Annual Meeting

    Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFkB Signaling and Macrophage Migration

    Nicholas A. Young1, Michael Bruss2, Mark Gardner3, William Willis3, Xiaokui Mo3, Giancarlo Valiente3, Yu Cao4, Zhongfa Liu4, Lai-Chu Wu1 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology and Immunology, The Ohio State University Wexner Medical Center, columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: The major obstacles to successful use of curcumin as an anti-inflammatory agent are its low solubility in water and rapid metabolism, which both translate…
  • Abstract Number: 1203 • 2014 ACR/ARHP Annual Meeting

    NK/NKT Cells from Early and Definite Systemic Sclerosis Patients Show Different Immunological Responses after IL-2 Stimulation

    Marta Cossu1, Lenny van Bon1, Stefan Nierkens2, Alessandro Santaniello3, Lorenzo Beretta4 and Timothy Radstake5, 1Department of Rheumatology, Clinical Immunology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2U-DAIR- Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands, 3Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 4Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 5Rheumatology, Clinical Immunology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: The innate immune system may be implicated in the fibrotic processes of systemic sclerosis (SSc); to date little has been done to unravel the…
  • Abstract Number: 1202 • 2014 ACR/ARHP Annual Meeting

    Type I Interferon Promotes Inflammatory Cytokine Production By Inhibiting Mir-146a Maturation in SLE

    Bo Qu1, Jianchang Cao2, Feifei Zhang2 and Nan Shen1,2,3, 1Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China, 2Institute of Health Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS) & Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai, China, Shanghai, China, 3The Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America, Cincinnati, OH

    Background/Purpose Systemic lupus erythematosus (SLE) is characterized by the uncontrolled inflammation along with over produced inflammatory cytokines, among which type I interferon (IFN) is recognized…
  • Abstract Number: 1201 • 2014 ACR/ARHP Annual Meeting

    Hypoxia Modulates Peptidyl Arginine Deiminase 4 Activity and Neutrophil Extracellular Trap Formation

    Akif A. Khawaja1,2, Charis Pericleous1, Luke W. Thomas3, Margaret Ashcroft3, Joanna C. Porter2 and Ian Giles1, 1Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 2Centre for Inflammation and Tissue Repair, Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom, 3Centre for Cell Signalling and Molecular Genetics, Centre for Cell Signalling and Molecular Genetics, University College London, London, United Kingdom

    Background/Purpose RA is an autoimmune rheumatic disease characterised by ACPA, endothelial dysfunction, platelet activation, synovial hyperplasia and hypoxia in affected joints. ACPA recognise citrullinated proteins,…
  • Abstract Number: 1220 • 2014 ACR/ARHP Annual Meeting

    Higher Inflammatory Response in Elderly Patients during Gout Attack

    Ji Ae Yang1, Jae Hyun Lee1, Eun Young Lee2, Eun Bong Lee1, Yeong Wook Song3 and Jin Kyun Park1, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Higher inflammatory response in elderly patients during gout attack Background/Purpose Clinical experiences suggest that gout attacks in elderly patients are accompanied by stronger systemic inflammatory…
  • Abstract Number: 1219 • 2014 ACR/ARHP Annual Meeting

    Lack of Gene-Diuretic Interactions on Risk of Incident Gout: The Nurses’ Health Study and Health Professionals Follow-up Study

    Ying Bao1, Tony R. Merriman2, Gary Curhan3, Eli A. Stahl4, David B. Mount5, Robert M. Plenge6, Peter Kraft7 and Hyon K. Choi8, 1Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, 2Department of Biochemistry, University of Otago, Dunedin, New Zealand, 3German Research Center for Environmental Health, Harvard Medical School, Boston, MA, 4Mt Sinai School of Medicine, New York City, NY, 5Renal Division, Brigham and Women's Hospital, Boston, MA, 6Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women's Hospital, Boston, MA, 7Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, 8Boston University School of Medicine, Boston, MA

    Background/Purpose: Diuretics, particularly thiazide and loop diuretics, increase the risk of gout, likely through urate transporters (e.g., OAT4) and volume depletion promoting urate reabsorption.  As…
  • Abstract Number: 1218 • 2014 ACR/ARHP Annual Meeting

    The Reduction of Serum Uric Acid Level Might Prevent Atherosclerosis in Mice

    Yoshitaka Kimura1,2, Tamiko Yanagida3, Akiko Onda4, Hajime Kono2, Maki Takayama2, Kurumi Asako2, Akiko Okamoto2, Hirotoshi Kikuchi2 and Toshihiro Nanki5, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 3Depart ment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 4Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 5Department of Clinical Research Medicine, Teikyo University, Tokyo, Japan

    Background/Purpose: Excess amount of uric acid in human body causes acute inflammation, gout. In addition, uric acid is identified as a danger signal and is…
  • Abstract Number: 1217 • 2014 ACR/ARHP Annual Meeting

    The Random Urine Uric Acid to Creatinine Ratio As a Predictor of 24-Hour Urine Uric Acid Excretion in Gout Patients

    Sang Tae Choi1, Jung-Soo Song2 and Eun-Hye Park2, 1Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea, 2Chung-Ang University College of Medicine, Seoul, South Korea

    Background/Purpose: Gout is an inflammatory disease resulted from an increased body pool of uric acid. The measurement of 24-hour uric acid excretion is important to…
  • Abstract Number: 1216 • 2014 ACR/ARHP Annual Meeting

    The Relationship Between Serum Homocysteine, Uric Acid and Renal Function in Chronic Gouty Patients: 2 Year Follow-up Results

    Eun-Hye Park1, Sang Tae Choi2 and Jung-Soo Song1, 1Chung-Ang University College of Medicine, Seoul, South Korea, 2Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea

    Background/Purpose: Hyperhomocysteinemia is one of the important factors for the endothelial cell damage and also a risk factor for cardiovascular events. Gout is known to…
  • Abstract Number: 1215 • 2014 ACR/ARHP Annual Meeting

    Circulating Mediators of Bone Remodeling in Patients with Tophaceous Gout

    Ashika Chhana1, Opetaia Aati2, Gregory Gamble2, Karen E. Callon1, Anthony Doyle3, Mark Roger4, Fiona M. McQueen5, Anne Horne2, Ian R. Reid2, Jillian Cornish1 and Nicola Dalbeth2, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3University of Auckland, Auckland, New Zealand, 4Department of Radiology, Auckland District Health Board, Auckland, New Zealand, 5Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

    Background/Purpose: Disordered bone remodeling has been implicated in the development of bone erosion in tophaceous gout.  The function of bone cells in the skeleton is…
  • Abstract Number: 1197 • 2014 ACR/ARHP Annual Meeting

    Febuxostat Inhibits Monosodium Urate Crystal-Induced IL-1beta Secretion and Cell Death Via ROS- and Intracellular ATP-Dependent Pathways

    Johji Nomura1, Nathalie Busso2, Mizuho Tamura1, Tsunefumi Kobayashi1 and Alexander So3, 1Pharmaceutical Development Research Laboratories, Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Tokyo, Japan, 2Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland, 3Rheumatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland

    Background/Purpose: In gout, monosodium urate (MSU) crystals trigger acute inflammation. MSU has been reported to activate NLRP3 inflammasome via ROS-dependent pathways, which result in IL-1beta…
  • Abstract Number: 1196 • 2014 ACR/ARHP Annual Meeting

    Inflammation Develops in a Toll-like Receptor 9-Independent Manner in Experimental Arthritis and Rheumatoid Arthritis

    Julie Mussard1, Matthieu Ribon1, Gaelle Clavel2, Marie-Christophe Boissier3 and Patrice Decker1, 1INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité and Rheumatology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France, 2Fondation Ophtalmologique A. De Rothschild, Paris cedex 19, France, 3INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité, Bobigny, France

    Background/Purpose Rheumatoid arthritis (RA) is an inflammatory disease of unknown etiology. Toll-like receptor (TLR) 9 recognizes pathogen-derived DNA and even self DNA under certain circumstances.…
  • « Previous Page
  • 1
  • …
  • 1969
  • 1970
  • 1971
  • 1972
  • 1973
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology